Literature DB >> 9621002

Preferential completion of human immunodeficiency virus type 1 proviruses initiated with tRNA3Lys rather than tRNA1,2Lys.

Z Zhang1, Q Yu, S M Kang, J Buescher, C D Morrow.   

Abstract

All retroviral genomes contain a nucleotide sequence designated as the primer binding site (PBS) which is complementary to the tRNA used for initiation of reverse transcription. For human immunodeficiency virus type 1 (HIV-1), all naturally occurring genomes have a PBS complementary to tRNA3Lys. However, within HIV-1 virions, there are approximately equal amounts of tRNA1Lys, tRNA2Lys, and tRNA3Lys. We have used an endogenous reverse transcription-PCR technique specific for the tRNA species within isolated HIV-1 virions to demonstrate that in addition to tRNA3Lys, tRNA1Lys and tRNA2Lys could be used for initiation of HIV-1 reverse transcription. Using a single-round infection assay which employed an HIV-1 genome with a gpt gene encoding xanthine-guanine phosphoribosyl transferase in place of the env gene, we generated cell lines resistant to mycophenolic acid. Analysis of the U5-PBS from single-cell clones revealed PBS complementary to tRNA3Lys, not tRNA1Lys or tRNA2Lys. A mutant HIV-1 genome was then created which would favor the completion of reverse transcription with tRNA1,2Lys. Using this provirus in the complementation system, we again found only genomes with a PBS complementary to tRNA3Lys from proviral DNA isolated from gpt-resistant single-cell colonies. Finally, infection of cells with a mutant HIV genome with a PBS complementary to tRNA1,2Lys resulted in gpt- resistant cell colonies which contained integrated provirions with a PBS complementary to tRNA1,2Lys. The results of these studies suggest that the selection of tRNA3Lys for initiation of HIV-1 reverse transcription occurs both at the initiation and at a postinitiation step in reverse transcription prior to integration of the proviral DNA.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9621002      PMCID: PMC110184     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Structure of the termini of DNA intermediates in the integration of retroviral DNA: dependence on IN function and terminal DNA sequence.

Authors:  M J Roth; P L Schwartzberg; S P Goff
Journal:  Cell       Date:  1989-07-14       Impact factor: 41.582

2.  Complete nucleotide sequence of the AIDS virus, HTLV-III.

Authors:  L Ratner; W Haseltine; R Patarca; K J Livak; B Starcich; S F Josephs; E R Doran; J A Rafalski; E A Whitehorn; K Baumeister
Journal:  Nature       Date:  1985 Jan 24-30       Impact factor: 49.962

3.  Complete nucleotide sequences of functional clones of the AIDS virus.

Authors:  L Ratner; A Fisher; L L Jagodzinski; H Mitsuya; R S Liou; R C Gallo; F Wong-Staal
Journal:  AIDS Res Hum Retroviruses       Date:  1987       Impact factor: 2.205

4.  Compilation of tRNA sequences and sequences of tRNA genes.

Authors:  M Sprinzl; T Hartmann; J Weber; J Blank; R Zeidler
Journal:  Nucleic Acids Res       Date:  1989       Impact factor: 16.971

5.  Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity.

Authors:  K A Page; N R Landau; D R Littman
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

6.  Deletions in the tRNA(Lys) primer-binding site of human immunodeficiency virus type 1 identify essential regions for reverse transcription.

Authors:  H Rhim; J Park; C D Morrow
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

7.  Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1.

Authors:  M Jiang; J Mak; A Ladha; E Cohen; M Klein; B Rovinski; L Kleiman
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

8.  Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells.

Authors:  J C Burns; T Friedmann; W Driever; M Burrascano; J K Yee
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

9.  tRNA's and priming of RNA-directed DNA synthesis in mouse mammary tumor virus.

Authors:  G Peters; C Glover
Journal:  J Virol       Date:  1980-07       Impact factor: 5.103

10.  Role of Pr160gag-pol in mediating the selective incorporation of tRNA(Lys) into human immunodeficiency virus type 1 particles.

Authors:  J Mak; M Jiang; M A Wainberg; M L Hammarskjöld; D Rekosh; L Kleiman
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

View more
  6 in total

1.  Essential regions of the tRNA primer required for HIV-1 infectivity.

Authors:  Q Yu; C D Morrow
Journal:  Nucleic Acids Res       Date:  2000-12-01       Impact factor: 16.971

2.  Does the HIV-1 primer activation signal interact with tRNA3(Lys) during the initiation of reverse transcription?

Authors:  Valérie Goldschmidt; Chantal Ehresmann; Bernard Ehresmann; Roland Marquet
Journal:  Nucleic Acids Res       Date:  2003-02-01       Impact factor: 16.971

Review 3.  Structural determinants and mechanism of HIV-1 genome packaging.

Authors:  Kun Lu; Xiao Heng; Michael F Summers
Journal:  J Mol Biol       Date:  2011-07-22       Impact factor: 5.469

4.  A nucleotide substitution in the tRNA(Lys) primer binding site dramatically increases replication of recombinant simian immunodeficiency virus containing a human immunodeficiency virus type 1 reverse transcriptase.

Authors:  Kelly Soderberg; Lynn Denekamp; Sarah Nikiforow; Karen Sautter; Ronald C Desrosiers; Louis Alexander
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

5.  Identification of a minimal region of the HIV-1 5'-leader required for RNA dimerization, NC binding, and packaging.

Authors:  Xiao Heng; Siarhei Kharytonchyk; Eric L Garcia; Kun Lu; Sai Sachin Divakaruni; Courtney LaCotti; Kedy Edme; Alice Telesnitsky; Michael F Summers
Journal:  J Mol Biol       Date:  2012-01-27       Impact factor: 5.469

6.  LC/MS analysis and deep sequencing reveal the accurate RNA composition in the HIV-1 virion.

Authors:  Anna Šimonová; Barbora Svojanovská; Jana Trylčová; Martin Hubálek; Ondřej Moravčík; Martin Zavřel; Marcela Pávová; Jan Hodek; Jan Weber; Josef Cvačka; Jan Pačes; Hana Cahová
Journal:  Sci Rep       Date:  2019-06-18       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.